Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deferiprone and Deferoxamine Combination in Thalassemia Major
NCT00103753Phase 4Unknown
- Sponsor
- Royal Brompton and Harefield hospitals
- Start
- May 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of deferiprone in beta thalassemia (2 arms), sponsored by Royal Brompton and Harefield hospitals. Primary endpoint: Myocardial T2* at 12 months. Status: unknown.
02
Drugs
deferiprone
03
Conditions
beta thalassemia
Beyond the preview
Go deeper on NCT00103753.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00103753.